The European Lung Foundation (ELF)Founded by ERS in 2000, ELF brings together patients and the public with respiratory professionals to positively influence lung health.Visit the ELF site
Abstract and clinical case submission for the European Respiratory Society (ERS) International Congress 2021 is now closed. See below for details on the review timelines and further abstract submission rounds.
Submitting abstracts for congress offers researchers the chance to share their preliminary findings at the world’s largest respiratory meeting, helping to boost research as it progresses and enabling the exchange of the latest findings in respiratory medicine and science. All congress abstracts are also published online in a supplement of the European Respiratory Journal.
There will be three opportunities to submit abstracts for the upcoming ERS congress:
Round
Description
Call open / close dates
Notification
First call
This call is the primary opportunity to submit your abstracts to be included in the ERS congress scientific programme. Submission is free.
15 December 2020 – 17 February 2021 at 23:59 CET.
June 2021.
Late-breaking abstracts
An opportunity to submit abstracts that contain novel data from all suitable experimental methods and study designs, which only became available after the first-round submission deadline in February 2021.
1 May – 14 June 2021 at 23:59 CEST.
July 2021.
Randomised controlled trial (RCT) abstracts
The most ground-breaking RCT submissions will be presented as part of the ‘Abstracts Leading to Evolution in Respiratory Medicine Trials’ sessions, offering a perfect platform to showcase important and very late-breaking clinical trial data from all respiratory disease areas.
1–14 July 2021 at 23:59 CEST.
August 2021.
How to submit abstracts
All abstracts are submitted online through myERS, allowing authors to review, edit and submit abstracts from one easy to access platform.
If you already have a myERS account, you can sign in and start the submission process right away. Navigate to ‘Abstracts/Cases’, then ‘Congress’ and then ‘Access Abstracts Platform’ to get started.
The recommended web browsers for accessing the submission platform are Google Chrome and Mozilla Firefox.
Authors who plan to apply for grants and sponsorship after abstracts have been accepted must ensure that they are listed as the corresponding author of the abstract, as this information will be sent to corresponding authors only.
For questions regarding abstract submission, please contact: abstracts@ersnet.org
Clinical cases
ERS encourages the respiratory community to submit interesting clinical cases for congress to support our offering of educational case-based sessions. This is a great opportunity to share your experiences, have cases presented in front of key opinion leaders in the field and actively contribute to the largest meeting in the respiratory calendar.
All clinical cases are submitted online through myERS, allowing contributors to review, edit and submit cases from one easy to access platform.
You may submit up to three cases per disease area, including:
Airway diseases
Interstitial lung diseases
Paediatric respiratory diseases
Pulmonary vascular diseases
Respiratory critical care
Respiratory infections
Sleep and breathing disorders
Thoracic oncology
When preparing cases for submission, please structure submissions under the following sections:
Case history
Investigations
Results and treatment
Conclusions and points for discussion
If you already have a myERS account, you can sign in and start the submission process right away. Navigate to ‘Abstracts/Cases’, then ‘Congress’ and then ‘Access Clinical Cases Platform’ to get started.
Case submitters will be notified about the outcome of their submissions in early June. Further details, such as the allocated session type and presentation scheduling, will be shared with the lead case submitter in early July.
Review and programme allocation
All clinical cases that are submitted for congress are reviewed for quality and suitability.
If accepted, the International Congress Programme Committee and case-based session experts will allocate cases to the following session types:
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.